全文获取类型
收费全文 | 272115篇 |
免费 | 24679篇 |
国内免费 | 13299篇 |
专业分类
耳鼻咽喉 | 3136篇 |
儿科学 | 5944篇 |
妇产科学 | 3575篇 |
基础医学 | 43488篇 |
口腔科学 | 8042篇 |
临床医学 | 23719篇 |
内科学 | 38907篇 |
皮肤病学 | 5830篇 |
神经病学 | 18156篇 |
特种医学 | 5758篇 |
外国民族医学 | 145篇 |
外科学 | 24251篇 |
综合类 | 43521篇 |
现状与发展 | 59篇 |
一般理论 | 2篇 |
预防医学 | 13197篇 |
眼科学 | 6394篇 |
药学 | 22151篇 |
65篇 | |
中国医学 | 8644篇 |
肿瘤学 | 35109篇 |
出版年
2024年 | 654篇 |
2023年 | 3734篇 |
2022年 | 7076篇 |
2021年 | 9813篇 |
2020年 | 8798篇 |
2019年 | 8250篇 |
2018年 | 8466篇 |
2017年 | 9276篇 |
2016年 | 9941篇 |
2015年 | 10858篇 |
2014年 | 16924篇 |
2013年 | 18653篇 |
2012年 | 16334篇 |
2011年 | 18214篇 |
2010年 | 15300篇 |
2009年 | 14462篇 |
2008年 | 15009篇 |
2007年 | 15123篇 |
2006年 | 13707篇 |
2005年 | 12358篇 |
2004年 | 10687篇 |
2003年 | 9152篇 |
2002年 | 7459篇 |
2001年 | 6437篇 |
2000年 | 5334篇 |
1999年 | 4729篇 |
1998年 | 4301篇 |
1997年 | 3843篇 |
1996年 | 3428篇 |
1995年 | 3054篇 |
1994年 | 2626篇 |
1993年 | 2157篇 |
1992年 | 1810篇 |
1991年 | 1611篇 |
1990年 | 1327篇 |
1989年 | 1160篇 |
1988年 | 1050篇 |
1987年 | 839篇 |
1986年 | 758篇 |
1985年 | 1030篇 |
1984年 | 897篇 |
1983年 | 608篇 |
1982年 | 700篇 |
1981年 | 528篇 |
1980年 | 488篇 |
1979年 | 338篇 |
1978年 | 235篇 |
1977年 | 184篇 |
1976年 | 145篇 |
1975年 | 62篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
101.
Masafumi Kumano Hideaki Miyake Isao Hara Junya Furukawa Atsushi Takenaka Masato Fujisawa 《International journal of urology》2007,14(4):336-338
BACKGROUND: The objective of this study was to evaluate the efficacy and safety of first-line high-dose chemotherapy (HDCT) combined with peripheral blood stem cell transplantation (PBSCT) for patients with advanced extragonadal germ cell tumors (EGGCT). METHODS: Six male patients with advanced non-seminomatous EGGCT were treated with HDCT combined with PBSCT following 2-3 cycles of conventional-dose induction chemotherapy. The regimens used for HDCT were carboplatin, etoposide and ifosfamide (ICE) in five patients and ICE plus paclitaxel (T-ICE) in one patient, and that for induction therapy was cisplatin, etoposide and bleomycin (PEB) in all patients. As a rule, HDCT was continuously administered until alpha-fetoprotein (AFP) and beta-human chorionic gonadotropin normalized (beta-HCG). RESULTS: Following 1-6 courses of HDCT (median, 4 courses), beta-HCG and AFP were normalized in all patients, and five and one patient were diagnosed as showing partial remission and stable disease, respectively. Five patients underwent surgical resection of residual tumors after HDCT, yielding necrotic tissue in two, mature teratoma in two, and viable cancer tissue in one, and the surgical margin was negative in all patients. At a median follow-up of 36 months, five patients were alive and disease-free, whereas the remaining one died of disease progression. Although all patients had grade 3 hematological toxicity, there was no treatment-related death by combining PBSCT. CONCLUSIONS: First-line HDCT with PBSCT could be safely administered to patients with advanced EGGCT, and the antitumor effect of this treatment was comparatively favorable. First-line HDCT therefore may represent an attractive option for patients with advanced EGGCT. 相似文献
102.
Tsuneharu Miki Yoichi Mizutani Hideyuki Akaza Seiichiro Ozono Taiji Tsukamoto Toshiro Terachi Katsusuke Naito Norio Nonomura Isao Hara Osamu Yoshida The Japan Blood Cell Transplantation Study Group for Testicular Germ Cell Tumor 《International journal of urology》2007,14(1):54-59
OBJECTIVE: Standard chemotherapy shows relatively low long-term survival in patients with poor-risk testicular germ cell tumor (GCT). First-line high-dose chemotherapy (HD-CT) may improve the result. High-dose carboplatin, etoposide, ifosfamide chemotherapy followed by autologous peripheral blood stem cell transplantation (PBSCT) was investigated as first-line chemotherapy in patients with advanced testicular GCT. METHODS: Fifty-five previously untreated testicular GCT patients with Indiana 'advanced disease' criteria received three cycles of bleomycin, etoposide and cisplatin (BEP) followed by one cycle of HD-CT plus PBSCT, if elevated serum tumor markers were observed after three cycles of the BEP regimen. RESULTS: Thirty patients were treated with BEP alone, because the tumor marker(s) declined to normal range. Twenty-five patients received BEP and HD-CT. One patient died of rhabdomyolysis due to HD-CT. Three and six (13% and 25%) out of 24 patients treated with BEP and HD-CT achieved marker-negative and marker-positive partial responses, respectively. The other patients achieved no change. Fifteen (63%) are alive and 14 (58%) are free of disease at a median follow-up time of 54 months. Severe toxicity included treatment-related death (4%). CONCLUSIONS: HD-CT with peripheral stem cell support can be successfully applied in a multicenter setting. HD-CT demonstrated modest anticancer activity for Japanese patients with advanced testicular GCT and was well tolerated. This regimen might be examined for further investigation in randomized trials in first-line chemotherapy for patients with poor-risk testicular GCT. 相似文献
103.
Mizuaki Sakura Satoru Kawakami Hitoshi Masuda Tsuyoshi Kobayashi Yukio Kageyama Kazunori Kihara 《International journal of urology》2007,14(12):1109-1112
Since 1998, we have performed minimum incision endoscopic surgery (MIES) for renal cell carcinoma (RCC). For seven dialysis patients with bilateral RCC, we have performed sequential bilateral MIES radical nephrectomy. It was carried out by retroperitoneal approach through a single minimum incision that narrowly permitted extraction of the specimen using endoscopy and direct stereovision, without trocar ports, without gas insufflation and without the insertion of the hands of operators into the operative field. Although six of the seven patients had multiple complications in addition to chronic renal failure (CRF), bilateral kidneys were successfully removed by sequential MIES radical nephrectomy without major operative complication. Postoperative recovery was prompt with all patients resuming oral feeding and walking by the second postoperative day. Sequential bilateral MIES radical nephrectomy, leaving the peritoneal cavity intact and without imposing circulatory stress caused by gas insufflation, is a feasible treatment for bilateral RCCs in dialysis patients. 相似文献
104.
C Diaz-Sarrio† N Salvatella-Danés† M Castro-Forns‡ A Nadal§ 《Journal of the European Academy of Dermatology and Venereology》2007,21(7):973-976
Langerhans cell sarcoma is a rare, aggressive tumour that may metastasize to many organs, likely leading to death of the patient within 1 year. We present the first case described in the literature in a patient who underwent transplantation. 相似文献
105.
目的研究引起安氏Ⅲ类错牙合畸形的病因。方法对50例安氏Ⅲ类错牙合患者和50例正常牙合人作病因问卷调查,将结果用logistic法分析,提取有效病因。结果共有慢性扁桃体炎、遗传因素、咬上唇3项病因进入方程。结论按贡献大小,长期慢性扁桃体炎、经常咬上唇和遗传因素是导致安氏Ⅲ类错牙合畸形的危险因素。 相似文献
106.
血小板活化因子在急性肝肾衰竭动物模型中对肾功能的影响 总被引:1,自引:0,他引:1
目的:了解血小板活化因子(PAF)在急性肝、肾衰竭动物模型中对肾功能的影响及可能的作用机制。方法:设4组大鼠,分别注射D-氨基半乳糖(D-GaLN)加内毒素(LPS),D-GaLN加PAF,D-GaLN加LPS加PAF受体拮抗剂及生理盐水,诱导急性肝、肾衰竭动物模型,测肝、肾功能指标并观察肝、肾组织病理改变。结果:注射D-GaLN大鼠的血清丙氨酸氨基转移酶、总胆红素比生理盐水组升高10倍以上,差异有显著性,病检有肝细胞坏死。注射PAF或LPS组与PAF受体拮抗剂组或生理盐水组比,肾功能指标差异有显著性。肾组织病检可见部分肾小管坏死。结论:PAF与急性肝、肾衰竭动物模型中的急性肾衰有关;PAF可能参与了内毒素相关的肝肾综合征(HRS)的形成;PAF受体拮抗剂对HRS可能有治疗作用。 相似文献
107.
Guo-Lin Wei Juri Melnik Jing-Li Luo Alan R. Sanger Karl T. Chuang 《Journal of electroanalytical chemistry (Lausanne, Switzerland)》2005,575(2):183-193
The performances of three widely different cathode materials (Pt, strontium-doped lanthanum manganite (LSM), and NiO) have been compared for use with proton conducting Li2SO4–Al2O3 composite electrolyte, using H2S–air and H2–air fuel cells operating at 600 °C. Surface analysis and electrochemical techniques were used to characterize fresh and used electrode materials. Pt or LSM cathodes each became covered with Li2SO4 and Al2O3 and, as a consequence, the fuel cells showed poor performance. In contrast, the NiO cathode catalyst did not become covered with Li2SO4 and good fuel cell performance was achieved. Exceptionally good current densities of over 100 mA/cm2 and power densities of over 30 mW/cm2 were obtained for H2S–air fuel cells having Mo–Ni–S anode catalysts. Slight agglomeration of NiO particles during fuel cell operation had only a minor effect on performance. 相似文献
108.
109.
目的:探讨细胞活素肿瘤坏死因子-α(TNF-α)、SNAP(S-Nitroso-Nacetyl-penicillamine)对胰腺癌细胞产生血管内皮生长因子A、C(VEGF-A、C)的调节.方法:用Northern杂交和Western杂交法分析6种人胰腺癌细胞株中VEGF-A、C基因和蛋白的表达;以TNF-α或SNAP刺激其中两个细胞株后用逆转录-聚合酶链式反应技术(RT-PCR)分析其VEGF-A、C基因的表达.结果:Northern杂交法显示这6种胰腺癌细胞株均有4.1kb VEGF-A基因和2.4kb VEGF-C基因的表达;Western杂交法显示它们均有分子量为43kD的VEGF-A蛋白质和分子量为55kD的VEGF-C蛋白质的表达.RT-PCR分析法显示:TNF-α使细胞株COLO-357产生VEGF-A、VEGF-C mRNA分别减少约1~2.5倍、1~2倍,使细胞株CAPAN-1产生VEGF-A、VEGF-C mRNA分别减少约1倍、1.6~2.5倍;而SNAP刺激细胞株COLO-357产生VEGF-A mRNA增加约5倍,刺激细胞株CAPAN-1产生VEGF-A mRNA增加约4倍,但对这两种细胞株产生VEGF-C mRNA均无明显刺激作用.结论:细胞活素TNF-α和低氧通过调节血管内皮生长因子A、C的表达而影响胰腺癌细胞的生物学特性,抑制癌细胞的增殖,促进其凋亡、死亡或进展、恶化. 相似文献
110.